THAIRM BIO
Thairm Bio is a Trust that invests in early-stage life science companies that show promise in developing breakthrough treatments for diseases with the potential to make a major improvement to patients' lives.
THAIRM BIO
Status:
Active
Similar Organizations
Cure Innovation Labs
Cure Innovation Labs is an incubator dedicated to advancing innovative early stage life science-focused companies.
Kapor Capital
Kapor Capital is an investment firm that invests in early-stage tech-enabled startups.
Lightchain Capital
Lightchain Capital focuses investments on early-stage life sciences companies.
Lime Street Ventures
Lime Street Ventures specializes in investing in early-stage tech and life sciences companies.
MagnaSci Ventures
MagnaSci Ventures is a Houston-based healthcare fund focused on investing in early-stage life science companies.
QuatroBio
QuatroBio is the management company for two early-stage life sciences companies.
Rogue Women’s Fund
Rogue Women’s Fund is a fund investing in early seed stage women-led companies.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-10 | 3Daughters | Thairm Bio investment in Seed Round - 3Daughters | 2.7 M USD |
| 2024-04-17 | Phlo | Thairm Bio investment in Venture Round - Phlo | 9 M GBP |
| 2024-04-04 | EnteroBiotix | Thairm Bio investment in Series B - EnteroBiotix | 27 M EUR |
| 2024-01-22 | 3Daughters | Thairm Bio investment in Seed Round - 3Daughters | 2 M USD |
| 2023-09-11 | Microplate Dx | Thairm Bio investment in Seed Round - Microplate Dx | 2.5 M GBP |
| 2023-06-01 | Pneumagen | Thairm Bio investment in Venture Round - Pneumagen | 8 M GBP |
| 2023-02-02 | Phlo | Thairm Bio investment in Series A - Phlo | 10 M GBP |
| 2022-01-19 | Pneumagen | Thairm Bio investment in Venture Round - Pneumagen | 3.8 M GBP |
| 2021-09-07 | EnteroBiotix | Thairm Bio investment in Series A - EnteroBiotix | 15.5 M GBP |
| 2021-01-21 | Pneumagen | Thairm Bio investment in Venture Round - Pneumagen | 2.5 M GBP |
More informations about "Thairm Bio"
Thairm Bio - Crunchbase Investor Profile & Investments
Thairm Bio is a Trust that invests in early-stage life science companies that show promise in developing breakthrough treatments for diseases with the potential to make a major …See details»
Thairm Bio investment portfolio - PitchBook
Thairm Bio's latest investment was on 31-Jul-2024 in Neupulse, a company within the Monitoring Equipment industry. Data Transparency. Meet our data hygiene team. Discover how our …See details»
Thairm Bio - Investments, Portfolio & Company Exits - Crunchbase
Jul 10, 2024 Thairm Bio has made 11 investments. Their most recent investment was on Jul 10, 2024, when 3Daughters raised. obfuscated. obfuscated. How many investments has this …See details»
Thairm Bio (Scotland) - Life-Sciences-Europe.com
Jan 1, 2012 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Thairm Bio - CB Insights
Jul 19, 2024 Thairm Bio has made 10 investments. Their latest investment was in Phlo as part of their Series B on April 17, 2024. Thairm Bio Investments Activity. View Investments Chart. …See details»
Pneumagen Raises £3.8 million to Advance the Phase II Clinical ...
Jan 19, 2022 Thairm Bio is a Trust that invests in early-stage life science companies that show promise in developing breakthrough treatments for diseases with the potential to make a major …See details»
Thairm Bio - Crunchbase
Companies like Thairm Bio include Kapor Capital, Lightchain Capital, and MagnaSci Ventures. Kapor Capital . Oakland, California, United States 17 Contacts 11-50 employees . Finance . …See details»
3Daughters Successfully Closes Over $2 million in First Tranche of …
Jan 29, 2024 This round was led by Thairm Bio, with a group of life science investors, and joined by the Argosy Foundation, Wexford Science and Technology, LLC, UMass Amherst, and other …See details»
Pneumagen raises £8m to accelerate Phase 2 clinical development …
Thairm Bio’s Mark Bamforth said, “We are delighted to continue our support for Pneumagen for the further development of Neumifil, which has a highly promising profile based on early pre …See details»
Thairm Bio – Investors Database - Unicorn Nest
Thairm Bio. SAVE. Total investments. 10. Average round size. 10M. Portfolio companies. 5. Lead investments. 2. Follow on index. 0.50. Areas of investment Biotechnology Internet Health Care …See details»
Pneumagen raises £8m to accelerate Phase 2 clinical …
Jun 1, 2023 Thairm Bio’s Mark Bamforth said, “We are delighted to continue our support for Pneumagen for the further development of Neumifil, which has a highly promising profile based on early pre ...See details»
EnteroBiotix secures $21.5M series A to advance microbiome drug ...
Sep 7, 2021 With the capital, the Scottish biopharmaceutical company will advance its pipeline for multiple disease areas to enhance the gut microbiome, the company announced Sept. 7. …See details»
EnteroBiotix Raises over $21m in Series A Financing to Advance its ...
Sep 7, 2021 Thairm Bio is a Trust that invests in early-stage life science companies that show promise in developing breakthrough treatments for diseases with the potential to make a major …See details»
3Daughters Successfully Closes Over $2 million in First Tranche of …
Jan 22, 2024 This round was led by Thairm Bio, with a group of life science investors, and joined by the Argosy Foundation, Wexford Science and Technology, LLC, UMass Amherst, and other …See details»
Thairm Bio - BioCentury Company Profiles - BCIQ
Sep 7, 2021 Thairm Bio - BioCentury Company Profiles for the biopharma industrySee details»
EnteroBiotix Raises over $21m in Series A Financing to Advance its ...
Sep 7, 2021 About Thairm Bio. Thairm Bio is a Trust that invests in early-stage life science companies that show promise in developing breakthrough treatments for diseases with the …See details»
3Daughters Secures Over $2M in Seed Funding for Novel IUD …
Jan 23, 2024 3Daughters, a clinical development company dedicated to advancing healthcare for women, has successfully closed over $2 million in the initial phase of its seed funding …See details»
Thairm Bio leads $21m funding of EnteroBiotix - Venture Capital …
Sep 7, 2021 Home News and Analysis Deals & Exits Thairm Bio leads $21m funding of EnteroBiotix. Return to search. News and Analysis. Thairm Bio leads $21m funding of …See details»
Series A - EnteroBiotix - 2021-09-07 - Crunchbase
Sep 7, 2021 Organization Name . EnteroBiotix . Announced Date Sep 7, 2021; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . £15.5M. Lead Investors. Edit …See details»